Shivalik Rasayan Ltd AI Stock Analysis
Want to see IN:SHIVALIK full AI Analyst Report?
Shivalik Rasayan Ltd (SHIVALIK) AI Stock Analysis
Shivalik Rasayan Ltd
(NSE:SHIVALIK)
The score is capped primarily by weak cash generation (negative operating and free cash flow) despite a solid, low-leverage balance sheet and steady revenue growth. Technicals are a meaningful positive with strong trend and momentum, but valuation is a clear headwind due to the high P/E and very low dividend yield.
Shivalik Rasayan Ltd (SHIVALIK) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 4.54B
- Dividend Yield
- 0.18%
- Average Volume (3M)
- 7,835
- Price to Earnings (P/E)
- 31.3
- Beta (1Y)
- 0.68
- Revenue Growth
- 13.01%
- EPS Growth
- 0.57%
- Country
- India
- Employees
- 267
- Sector
- General
- Sector Strength
- 55
- Industry
- Agricultural Inputs
Shivalik Rasayan Ltd Business Overview & Revenue Model
Company Description
Established on March 16, 1979, by Rahul Bishnoi, Shivalik Rasayan Limited is an Indian firm specializing in the creation of pharmaceutical and agrochemical products. Based in New Delhi, its offerings notably feature organophosphorous-based insecticid...
Shivalik Rasayan Ltd Financial Statement Overview
Summary
Steady revenue growth and a conservatively levered balance sheet support the fundamentals, but the profile is materially weakened by consistently negative free cash flow and negative operating cash flow in recent years, alongside thinner margins versus earlier peaks.
Income Statement
66PositiveBalance Sheet
78PositiveCash Flow
22Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.75B | 3.68B | 3.12B | 2.72B | 2.34B | 2.07B |
| Gross Profit | 1.45B | 1.00B | 805.70M | 1.32B | 1.20B | 1.13B |
| EBITDA | 463.56M | 498.42M | 485.11M | 368.00M | 439.95M | 504.71M |
| Net Income | 136.70M | 121.36M | 166.96M | 127.17M | 212.35M | 256.06M |
Balance Sheet | ||||||
| Total Assets | 0 | 8.19B | 7.34B | 6.92B | 5.78B | 4.88B |
| Cash, Cash Equivalents and Short-Term Investments | 343.68M | 343.68M | 279.69M | 377.38M | 306.71M | 707.58M |
| Total Debt | 0 | 1.14B | 938.83M | 859.67M | 655.12M | 411.22M |
| Total Liabilities | -5.99B | 2.20B | 1.98B | 1.85B | 1.59B | 1.24B |
| Stockholders Equity | 5.99B | 5.99B | 4.15B | 3.90B | 3.10B | 2.87B |
Cash Flow | ||||||
| Free Cash Flow | -267.77M | -581.61M | -294.37M | -757.31M | -821.81M | -138.32M |
| Operating Cash Flow | -168.43M | -414.68M | -86.05M | -80.75M | -189.49M | 111.34M |
| Investing Cash Flow | -157.64M | -233.18M | -208.31M | -743.08M | -707.72M | -233.56M |
| Financing Cash Flow | 514.76M | 711.84M | 196.69M | 894.49M | 496.34M | 782.07M |
Shivalik Rasayan Ltd Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SHIVALIK, the sentiment is Negative. The current price of 283.50 is below the 20-day moving average (MA) of 303.20, below the 50-day MA of 344.01, and above the 200-day MA of 281.44, indicating a neutral trend. The MACD of -12.75 indicates Positive momentum. The RSI at 34.73 is Neutral, neither overbought nor oversold. The STOCH value of 14.43 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:SHIVALIK.
Shivalik Rasayan Ltd Peers Comparison
Overall Rating
IN:DICIND69Neutral
IN:PODDARMENT68Neutral
IN:SRD61Neutral
IN:SHIVALIK60Neutral
IN:MANORG50Neutral
IN:BODALCHEM47Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 69Neutral | INR 4.52B | 17.74 | ― | 0.62% | 17.22% | 25.44% | |
| 68Neutral | INR 2.60B | 17.55 | ― | 1.64% | 4.50% | -17.13% | |
| 61Neutral | INR 2.94B | 12.52 | ― | 0.11% | 19.82% | 92.88% | |
| 60Neutral | INR 4.72B | 31.29 | ― | 0.18% | 13.01% | 0.57% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 50Neutral | INR 3.61B | 17.51 | ― | ― | 34.60% | -13.51% | |
| 47Neutral | INR 18.94B | 12.84 | ― | ― | 44.89% | 306.54% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:SHIVALIK | Shivalik Rasayan Ltd | 283.50 | -120.05 | -29.75% | |
| IN:BODALCHEM | Bodal Chemicals Limited | 147.60 | 92.39 | 167.34% | |
| IN:DICIND | DIC India Limited | 481.75 | -20.65 | -4.11% | |
| IN:MANORG | Mangalam Organics Ltd | 418.45 | -27.40 | -6.15% | |
| IN:PODDARMENT | Poddar Pigments Limited | 245.00 | -15.48 | -5.94% | |
| IN:SRD | Shankar Lal Rampal Dye-Chem Ltd. | 44.75 | -19.33 | -30.16% |
Shivalik Rasayan Ltd Corporate Events
Shivalik Rasayan Publishes EGM Voting Results, Highlights Governance Focus
Shivalik Rasayan Limited disclosed the voting results of its Extraordinary General Meeting held on August 20, 2026 in Dehradun, in line with SEBI listing requirements. The meeting saw participation from promoters and a sizeable public shareholder gro...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 17, 2026
